Officials from Amedica Corp., a biomaterials company, announced a collaboration with Kyocera Industrial Ceramics Corp., a worldwide leading ceramics producer, to manufacture medical devices from Amedica’s Silicon Nitride biomaterial at Kyocera’s Vancouver, Wash., facility. This collaboration includes the manufacture of Amedica’s FDA approved Silicon Nitride spinal interbody devices and will broaden Amedica’s ability to meet market demand.
As a biomaterial, Silicon Nitride has been shown to help promote bone growth and has anti-infective properties. Devices made from Silicon Nitride are semi-radiolucent with clearly visible boundaries enabling an exact view of intraoperative placement and postoperative fusion assessment via common imaging modalities. Amedica believes that these are the essential characteristics surgeons seek when choosing the ideal spinal interbody implant for patients. Amedica has sold more than 14,000 of these devices worldwide.
Eric Olson, president and CEO of Amedica Corp. says, “There is an unmet need for advanced biomaterials in Orthopedics and Spine. We are seeing an increasing interest for our Silicon Nitride interbody devices and increased interest in this material for use in other applications and want to ensure a consistent supply for surgeons and more importantly patients. As the world’s No. 1 producer of advanced ceramics with vast experience in ensuring market demand is consistently fulfilled for innovative products, Kyocera is the ideal partner to help broaden availability of our novel biomaterial devices.”